Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Brief Summary: The purpose of this multi-center pilot study is to determine if the drug tocilizumab (Actemra) is effective in the treatment of patients with refractory adult polymyositis (PM) and dermatomyositis (DM).